Cabaletta Historical Balance Sheet

CABA Stock

USD 1.67 0.01 0.60%

Trend analysis of Cabaletta Bio balance sheet accounts such as Other Current Liab of 12.8 M, Total Current Liabilities of 28.4 M or Total Stockholder Equity of 116.6 M provides information on Cabaletta Bio's total assets, liabilities, and equity, which is the actual value of Cabaletta Bio to its prevalent stockholders. By breaking down trends over time using Cabaletta Bio balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Cabaletta Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cabaletta Bio is a good buy for the upcoming year.

Build AI portfolio with Cabaletta Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.

About Cabaletta Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Cabaletta Bio at a specified time, usually calculated after every quarter, six months, or one year. Cabaletta Bio Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cabaletta Bio and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cabaletta currently owns. An asset can also be divided into two categories, current and non-current.

Cabaletta Bio Balance Sheet Chart

At present, Cabaletta Bio's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 28.4 M, whereas Total Assets are forecasted to decline to about 133.7 M.

Total Assets Other Current Liab Total Current Liabilities Accounts Payable

Total Assets

Total assets refers to the total amount of Cabaletta Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cabaletta Bio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Cabaletta Bio balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Cabaletta Bio are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents Cabaletta Bio obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Cabaletta Bio are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most accounts from Cabaletta Bio's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Cabaletta Bio current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.At present, Cabaletta Bio's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 28.4 M, whereas Total Assets are forecasted to decline to about 133.7 M.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	2.7M	7.9M	12.2M	12.8M
Total Assets	117.0M	253.7M	185.0M	133.7M

Other Current Liab Total Assets

Cabaletta Bio balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse	Other Stockholder Equity	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Short Long Term Debt Total	Other Assets	Other Current Assets	Deferred Long Term Liab	Property Plant And Equipment Net	Property Plant And Equipment Gross	Property Plant Equipment	Retained Earnings Total Equity
Total Assets		0.81	0.77	0.99	0.9	-0.97	-0.81	0.86	0.99	1.0	0.48	0.0	0.91	0.91	0.48	0.99	1.0	0.99	-0.9	-0.28	0.79	-0.36	0.64	0.67	0.79	-0.78
Other Current Liab	0.81		0.98	0.78	0.71	-0.86	-0.97	0.97	0.82	0.8	0.64	0.0	0.89	0.96	0.51	0.78	0.8	0.77	-0.68	-0.42	0.63	-0.8	0.9	0.92	0.74	-0.8
Total Current Liabilities	0.77	0.98		0.73	0.65	-0.81	-0.99	0.97	0.76	0.75	0.68	0.02	0.87	0.96	0.53	0.73	0.75	0.72	-0.62	-0.36	0.55	-0.84	0.97	0.98	0.79	-0.8
Total Stockholder Equity	0.99	0.78	0.73		0.92	-0.98	-0.77	0.83	0.98	0.99	0.46	-0.14	0.9	0.89	0.34	1.0	0.99	0.99	-0.92	-0.27	0.8	-0.32	0.6	0.63	0.76	-0.76
Net Tangible Assets	0.9	0.71	0.65	0.92		-0.93	-0.68	0.71	0.92	0.9	0.26	-0.15	0.91	0.8	0.27	0.92	0.9	0.9	-0.98	-0.11	0.73	-0.3	0.52	0.53	0.65	-0.69
Net Debt	-0.97	-0.86	-0.81	-0.98	-0.93		0.82	-0.87	-0.98	-0.97	-0.42	0.13	-0.94	-0.93	-0.35	-0.98	-0.97	-0.97	0.92	0.34	-0.78	0.49	-0.67	-0.7	-0.7	0.77
Retained Earnings	-0.81	-0.97	-0.99	-0.77	-0.68	0.82		-0.99	-0.8	-0.79	-0.72	-0.01	-0.9	-0.97	-0.55	-0.77	-0.79	-0.76	0.67	0.29	-0.58	0.77	-0.96	-0.97	-0.86	0.86
Accounts Payable	0.86	0.97	0.97	0.83	0.71	-0.87	-0.99		0.85	0.85	0.69	0.03	0.91	0.99	0.55	0.83	0.85	0.83	-0.71	-0.31	0.64	-0.72	0.92	0.94	0.85	-0.88
Cash	0.99	0.82	0.76	0.98	0.92	-0.98	-0.8	0.85		0.99	0.42	0.02	0.91	0.9	0.48	0.98	0.99	0.99	-0.91	-0.31	0.77	-0.38	0.62	0.65	0.74	-0.75
Cash And Short Term Investments	1.0	0.8	0.75	0.99	0.9	-0.97	-0.79	0.85	0.99		0.45	0.0	0.91	0.9	0.47	0.99	1.0	1.0	-0.9	-0.28	0.79	-0.35	0.62	0.65	0.77	-0.77
Common Stock Shares Outstanding	0.48	0.64	0.68	0.46	0.26	-0.42	-0.72	0.69	0.42	0.45		-0.21	0.5	0.63	0.3	0.46	0.44	0.4	-0.24	-0.2	0.37	-0.4	0.69	0.71	0.8	-0.64
Non Current Liabilities Total	0.0	0.0	0.02	-0.14	-0.15	0.13	-0.01	0.03	0.02	0.0	-0.21		-0.07	-0.04	0.82	-0.14	0.0	0.01	0.12	0.0	-0.1	-0.06	0.03	0.02	-0.03	0.04
Capital Surpluse	0.91	0.89	0.87	0.9	0.91	-0.94	-0.9	0.91	0.91	0.91	0.5	-0.07		0.95	0.42	0.9	0.91	0.89	-0.92	-0.1	0.71	-0.56	0.77	0.79	0.8	-0.89
Other Stockholder Equity	0.91	0.96	0.96	0.89	0.8	-0.93	-0.97	0.99	0.9	0.9	0.63	-0.04	0.95		0.49	0.89	0.9	0.88	-0.79	-0.31	0.7	-0.69	0.89	0.91	0.84	-0.86
Total Liab	0.48	0.51	0.53	0.34	0.27	-0.35	-0.55	0.55	0.48	0.47	0.3	0.82	0.42	0.49		0.34	0.46	0.44	-0.26	-0.17	0.23	-0.37	0.52	0.53	0.51	-0.42
Net Invested Capital	0.99	0.78	0.73	1.0	0.92	-0.98	-0.77	0.83	0.98	0.99	0.46	-0.14	0.9	0.89	0.34		0.99	0.99	-0.92	-0.27	0.8	-0.32	0.6	0.63	0.76	-0.76
Total Current Assets	1.0	0.8	0.75	0.99	0.9	-0.97	-0.79	0.85	0.99	1.0	0.44	0.0	0.91	0.9	0.46	0.99		1.0	-0.91	-0.28	0.8	-0.35	0.62	0.65	0.76	-0.77
Net Working Capital	0.99	0.77	0.72	0.99	0.9	-0.97	-0.76	0.83	0.99	1.0	0.4	0.01	0.89	0.88	0.44	0.99	1.0		-0.91	-0.28	0.8	-0.32	0.58	0.61	0.73	-0.75
Short Long Term Debt Total	-0.9	-0.68	-0.62	-0.92	-0.98	0.92	0.67	-0.71	-0.91	-0.9	-0.24	0.12	-0.92	-0.79	-0.26	-0.92	-0.91	-0.91		0.05	-0.8	0.27	-0.48	-0.51	-0.64	0.72
Other Assets	-0.28	-0.42	-0.36	-0.27	-0.11	0.34	0.29	-0.31	-0.31	-0.28	-0.2	0.0	-0.1	-0.31	-0.17	-0.27	-0.28	-0.28	0.05		-0.41	0.42	-0.29	-0.29	0.02	-0.14
Other Current Assets	0.79	0.63	0.55	0.8	0.73	-0.78	-0.58	0.64	0.77	0.79	0.37	-0.1	0.71	0.7	0.23	0.8	0.8	0.8	-0.8	-0.41		-0.24	0.41	0.43	0.49	-0.5
Deferred Long Term Liab	-0.36	-0.8	-0.84	-0.32	-0.3	0.49	0.77	-0.72	-0.38	-0.35	-0.4	-0.06	-0.56	-0.69	-0.37	-0.32	-0.35	-0.32	0.27	0.42	-0.24		-0.87	-0.86	-0.38	0.47
Property Plant And Equipment Net	0.64	0.9	0.97	0.6	0.52	-0.67	-0.96	0.92	0.62	0.62	0.69	0.03	0.77	0.89	0.52	0.6	0.62	0.58	-0.48	-0.29	0.41	-0.87		1.0	0.78	-0.74
Property Plant And Equipment Gross	0.67	0.92	0.98	0.63	0.53	-0.7	-0.97	0.94	0.65	0.65	0.71	0.02	0.79	0.91	0.53	0.63	0.65	0.61	-0.51	-0.29	0.43	-0.86	1.0		0.8	-0.77
Property Plant Equipment	0.79	0.74	0.79	0.76	0.65	-0.7	-0.86	0.85	0.74	0.77	0.8	-0.03	0.8	0.84	0.51	0.76	0.76	0.73	-0.64	0.02	0.49	-0.38	0.78	0.8		-0.87
Retained Earnings Total Equity	-0.78	-0.8	-0.8	-0.76	-0.69	0.77	0.86	-0.88	-0.75	-0.77	-0.64	0.04	-0.89	-0.86	-0.42	-0.76	-0.77	-0.75	0.72	-0.14	-0.5	0.47	-0.74	-0.77	-0.87

Click cells to compare fundamentals

Cabaletta Bio Account Relationship Matchups

Cabaletta Bio balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	114.7M	126.3M	117.0M	253.7M	185.0M	133.7M
Other Current Liab	3.9M	6.0M	2.7M	7.9M	12.2M	12.8M
Total Current Liabilities	5.2M	8.4M	9.5M	16.0M	27.1M	28.4M
Total Stockholder Equity	109.5M	118.0M	104.5M	236.2M	152.3M	116.6M
Net Tangible Assets	138.3M	109.5M	116.6M	104.5M	120.2M	84.0M
Net Debt	(101.4M)	(122.2M)	(76.5M)	(188.2M)	(148.4M)	(155.8M)
Retained Earnings	(66.3M)	(112.6M)	(165.6M)	(233.2M)	(349.1M)	(331.6M)
Accounts Payable	1.2M	2.3M	2.5M	4.5M	4.9M	5.2M
Cash	101.4M	122.2M	81.6M	193.2M	164.0M	114.4M
Non Current Assets Total	1.2M	1.8M	8.1M	9.2M	18.4M	19.3M
Non Currrent Assets Other	299K	357K	565K	1.7M	2.3M	2.4M
Cash And Short Term Investments	108.7M	122.2M	106.5M	241.2M	164.0M	125.4M
Common Stock Shares Outstanding	23.1M	25.7M	29.3M	40.9M	49.5M	29.2M
Liabilities And Stockholders Equity	114.7M	126.3M	117.0M	253.7M	185.0M	133.7M
Non Current Liabilities Total	1.2M	2.3M	3.0M	1.5M	5.6M	5.9M
Capital Surpluse	1.8M	171.3M	175.8M	270.1M	310.6M	326.2M
Other Stockholder Equity	175.8M	230.5M	270.1M	469.4M	501.4M	526.5M
Total Liab	5.2M	8.4M	12.4M	17.5M	32.7M	17.1M
Net Invested Capital	109.5M	118.0M	104.5M	236.2M	152.3M	116.6M
Total Current Assets	113.5M	124.5M	108.8M	244.5M	166.7M	128.2M
Net Working Capital	108.4M	116.2M	99.3M	228.5M	139.6M	118.5M
Other Assets	299.0	357K	565K	1.0	1.15	1.09
Other Current Assets	7.9M	2.3M	2.3M	6.5M	2.7M	3.7M
Property Plant And Equipment Net	890K	1.4M	7.6M	7.5M	16.1M	16.9M
Property Plant And Equipment Gross	890K	2.6M	9.9M	11.2M	21.6M	22.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GOOG	Alphabet Inc Class C
V	Visa Class A

When determining whether Cabaletta Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cabaletta Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cabaletta Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cabaletta Bio Stock:

How To Invest In Cabaletta

Details

Is Cabaletta Stock a good investment?

Details

What is Cabaletta Bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.

You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. If investors know Cabaletta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cabaletta Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.54)

Return On Assets

(0.41)

Return On Equity

(0.74)

The market value of Cabaletta Bio is measured differently than its book value, which is the value of Cabaletta that is recorded on the company's balance sheet. Investors also form their own opinion of Cabaletta Bio's value that differs from its market value or its book value, called intrinsic value, which is Cabaletta Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cabaletta Bio's market value can be influenced by many factors that don't directly affect Cabaletta Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cabaletta Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cabaletta Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Cabaletta Historical Balance Sheet

About Cabaletta Balance Sheet Analysis

Cabaletta Bio Balance Sheet Chart

Total Assets

Total Current Liabilities

Accounts Payable

Cabaletta Bio balance sheet Correlations

Cabaletta Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cabaletta Bio balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Cash And Short Term Investments
Net Working Capital	+ 1.0	Cash And Short Term Investments
Net Working Capital	+ 1.0	Total Current Assets

Accounts Payable	- 0.99	Retained Earnings
Retained Earnings	- 0.99	Total Current Liabilities
Net Invested Capital	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Short Long Term Debt Total	- 0.98	Net Tangible Assets
Net Debt	- 0.98	Total Stockholder Equity